James S. Wysock

Urology
222 E 41st St
New York, NY 10017

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications

Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity.

Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity.

Journal: The Journal of urology
Published: June 10, 2026

Focal Cryo-ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate Cancer.

Focal Cryo-ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate Cancer.

Journal: Urology
Published: January 09, 2026

Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results.

Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results.

Journal: European radiology
Published: September 29, 2025

Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.

Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.

Journal: European urology
Published: September 26, 2025

MRI performance to identify clinically significant prostate cancer following focal cryo-ablation.

MRI performance to identify clinically significant prostate cancer following focal cryo-ablation.

Journal: BJUI compass
Published: September 10, 2025

Factors predicting sexual function dissatisfaction following primary partial gland cryoablation.

Factors predicting sexual function dissatisfaction following primary partial gland cryoablation.

Journal: The journal of sexual medicine
Published: May 18, 2025

Routine prostate biopsies not needed after cryotherapy if surveillance MRI is normal.

Routine prostate biopsies not needed after cryotherapy if surveillance MRI is normal.

Journal: BJU international
Published: May 14, 2025

Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.

Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.

Journal: European urology
Published: March 17, 2025

Stimulated Raman Histology and Artificial Intelligence Provide Near Real-Time Interpretation of Radical Prostatectomy Surgical Margins.

Stimulated Raman Histology and Artificial Intelligence Provide Near Real-Time Interpretation of Radical Prostatectomy Surgical Margins.

Journal: The Journal of urology
Published: December 17, 2024

Implications of MRI contrast enhancement following focal prostate cancer cryoablation.

Implications of MRI contrast enhancement following focal prostate cancer cryoablation.

Journal: The Canadian journal of urology
Published: October 27, 2024

Functional, oncological, regret and complications following partial gland cryo-ablation for low-risk prostate cancer associated with MPMRI targets.

Functional, oncological, regret and complications following partial gland cryo-ablation for low-risk prostate cancer associated with MPMRI targets.

Journal: Urologic oncology
Published: October 11, 2024

Reply to Editorial Comment on "Predictors of Contralateral Disease in Men With Unilateral Lesions on Multiparametric MRI".

Reply to Editorial Comment on "Predictors of Contralateral Disease in Men With Unilateral Lesions on Multiparametric MRI".

Journal: Urology
Published: August 26, 2024
Showing 1-12 of 80

Last Updated: 09/26/2026